Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
312,579,912
-
Total 13F shares
-
312,166,252
-
Share change
-
-7,706,903
-
Total reported value
-
$2,460,003,736
-
Put/Call ratio
-
96%
-
Price per share
-
$7.88
-
Number of holders
-
283
-
Value change
-
-$41,517,194
-
Number of buys
-
154
-
Number of sells
-
125
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q3 2025
As of 30 Sep 2025,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
283 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
312,166,252 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Avoro Capital Advisors LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, Vestal Point Capital, LP, CITADEL ADVISORS LLC, and Point72 Asset Management, L.P..
This page lists
284
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.